Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Molecular Devices Corp. (NasdaqNM:MDCC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
1311 Orleans Drive
Sunnyvale, CA 94089
Phone: (408) 747-1700
Fax: (408) 747-3699
Email: info@moldev.com
Employees (last reported count): 332
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 53%
·Over the last 6 months:
 · one insider buy; 1,000  shares
 · 3 insider sells; 59.0K shares
  (0.7% of insider shares)
·Institutional: 95% (201% of float)
(213 institutions)
·Net Inst. Buying: 988.0K shares (+5.78%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Molecular Devices Corporation is a developer of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high throughput and cost effective identification and evaluation of drug candidates. The Company's instrument systems are based on its advanced core technologies, which integrate its expertise in engineering, molecular and cell biology and chemistry. The Company's systems are fundamental tools for drug discovery and life sciences research, and its MAXline series of microplate readers and its FLIPR Cell Analysis systems are market share leaders in their respective markets.
More from Market Guide: Expanded Business Description

Financial Summary
Molecular Devices Corporation designs, develops, manufactures and markets proprietary, high performance bioanalytical measurement systems designed to improve the drug development process. For the six months ended 6/30/01, revenues rose 1% to $44.7 million. Net income rose 27% to $4.1 million. Revenues reflect increased sales of the Company's Flexstation(TM)and Skatron product lines. Earnings also reflect a decrease in research and development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Joseph Keegan, Ph.D., 47
Pres and CEO
$535K$2.5M
Timothy Harkness, 34
VP, Fin. and CFO
291K1.5M
Robert Murray, 53
VP-Operations
260K823K
Tony Lima, 42
VP - Sales and Service
286K154K
John Senaldi, 36
VP of Worldwide Marketing
254K1.8M
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:MDCCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 25-June-2001
$16.38 
Recent Price$22.69 
52-Week High
on 28-Sep-2000
$112.50 
Beta1.52 
Daily Volume (3-month avg)228.0K
Daily Volume (10-day avg)225.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-74.0%
52-Week Change
relative to S&P500
-65.1%
Share-Related Items
Market Capitalization$384.8M
Shares Outstanding17.0M
Float8.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$10.30 
Earnings (ttm)-$0.28 
Earnings (mrq)$0.14 
Sales (ttm)$5.77 
Cash (mrq)$5.90 
Valuation Ratios
Price/Book (mrq)2.20 
Price/EarningsN/A 
Price/Sales (ttm)3.93 
Income Statements
Sales (ttm)$96.5M
EBITDA (ttm)-$849.0K
Income available to common (ttm)-$4.08M
Profitability
Profit Margin (ttm)-4.2%
Operating Margin (ttm)-3.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-2.41%
Return on Equity (ttm)-2.63%
Financial Strength
Current Ratio (mrq)13.99 
Debt/Equity (mrq)0 
Total Cash (mrq)$97.6M
Short Interest
As of 8-Aug-2001
Shares Short1.29M
Percent of Float16.1%
Shares Short
(Prior Month)
1.30M
Short Ratio4.62 
Daily Volume279.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.